Overview
Asghar Nasir practices practicing medicine in Karachi, Pakistan.
Their clinical expertise encompasses Pitt-Hopkins Syndrome, Severe Acute Respiratory Syndrome (SARS), Hyperventilation, and COVID-19.
They are actively involved in clinical research, co-authoring 15 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Asghar Nasir
Is Asghar Nasir a top-rated expert for Pitt-Hopkins Syndrome?
MediFind is an objective health platform that identifies experts based on real-world data. Asghar Nasir is classified as an Experienced expert for Pitt-Hopkins Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Asghar Nasir participate in research or clinical trials?
Yes. Asghar Nasir has published 15 articles and abstracts on conditions like Pitt-Hopkins Syndrome. You can view a list of Asghar Nasir's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- COVID-19Nasir isExperienced. Learn about COVID-19.
- HyperventilationNasir isExperienced. Learn about Hyperventilation.
- Pitt-Hopkins SyndromeNasir isExperienced. Learn about Pitt-Hopkins Syndrome.
- Severe Acute Respiratory Syndrome (SARS)